Psilocybin compositions
AssigneeTurtle Bear Holdings, LLC
InventorPaul Edward STAMETS
Life of this patent
Estimating the term…
Abstract
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
Claims17
A pharmaceutical formulation comprising:
- 0.1 mg to 10 mg of psilocybin or psilocin;
- and
- one or more pharmaceutical excipients selected from acidifying agents, alkalizing agents, buffering agents, antimicrobial preservatives, antioxidants, or tablet disintegrants.
A method for reducing symptoms of depression in a subject in need thereof comprising:
- administering a dosage form sufficient to reduce one or more symptoms of depression in the subject, the dosage form comprising:
- 0.1 mg to 10 mg of psilocybin or psilocin;
- and
- one or more pharmaceutical excipients selected from acidifying agents, alkalizing agents, buffering agents, antimicrobial preservatives, antioxidants, or tablet disintegrants.
The method of claim 8, wherein the dosage form further comprises an extract of Hericium erinaceus comprising 0.1 mg to 200 mg of erinacines or hericenones.
A method for increasing cognitive function in a subject, comprising:
- administering a dosage form sufficient to increase cognitive function in the subject, the dosage form comprising:
- 0.1 mg to 10 mg of psilocybin or psilocin;
- and
- one or more pharmaceutical excipients selected from acidifying agents, alkalizing agents, buffering agents, antimicrobial preservatives, antioxidants, or tablet disintegrants.
The method of claim 15, wherein the dosage form further comprises an extract of Hericium erinaceus comprising 0.1 mg to 200 mg of erinacines or hericenones.
The method of claim 15, wherein the dosage form further comprises 1 mg to 50 mg of niacin.
Dependencies are inferred from the claim text.